Back to search
ALS - Amyotrophic Lateral Sclerosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which ALS - Amyotrophic Lateral Sclerosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which ALS - Amyotrophic Lateral Sclerosis trials you may qualify forThis study is testing a tongue exercise program for people living with ALS to see if it can help support speech and swallowing. All participants will receive th…
INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
The goal of this clinical trial is to evaluate whether psilocybin therapy can effectively treat depression and psychological distress in adult patients with COP…
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the t…
The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with a…
Weight loss is a known negative prognostic factor in amyotrophic lateral sclerosis (ALS). Over the last years, various interventional studies targeting the ener…
The purpose of this study is to evaluate the safety of oral edaravone at a dose of 105 mg administered once daily for 10 days out of a 14-day period, followed b…
Routine MRI is normal in motor neuron diseases such as ALS. However, advanced MRI techniques can provide an objective measure of degeneration (a "biomarker") by…
Background: \- Some people have a mutation in the C9ORF72 gene that causes amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). The mutation c…